Nautilus Biotechnology, Inc. Number of Reportable Segments
Nautilus Biotechnology, Inc. (NAUT) reported Number of Reportable Segments of 1 segment for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-07-28
- Nautilus Biotechnology, Inc. number of reportable segments for fiscal 2023 was 1.00 Segment, a 0.00% change from fiscal 2022.
- Nautilus Biotechnology, Inc. number of reportable segments for fiscal 2022 was 1.00 Segment, a 0.00% change from fiscal 2021.
- Nautilus Biotechnology, Inc. number of reportable segments for fiscal 2021 was 1.00 Segment.
Segment
| Period end | Number of Reportable Segments 12 month |
|---|---|
| 2023-12-31 | 1.00 Segment 10-K · filed 2024-02-28 |
| 2022-12-31 | 1.00 Segment 10-K · filed 2023-02-23 |
| 2021-12-31 | 1.00 Segment 10-K · filed 2022-02-24 |
segment
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 6 month | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|---|---|
| 2026-06-30 | 1.00 segment 10-Q · filed 2026-07-28 | |||
| 2026-03-31 | 1.00 segment 10-Q · filed 2026-04-28 | |||
| 2025-12-31 | 1.00 segment 10-K · filed 2026-02-26 | |||
| 2025-09-30 | 1.00 segment 10-Q · filed 2025-10-28 | |||
| 2025-06-30 | 1.00 segment 10-Q · filed 2025-07-31 | |||
| 2025-03-31 | 1.00 segment 10-Q · filed 2025-04-29 | |||
| 2024-12-31 | 1.00 segment 10-K · filed 2025-02-27 | |||
| 2024-09-30 | 1.00 segment 10-Q · filed 2024-10-29 | |||
| 2024-06-30 | 1.00 segment 10-Q · filed 2024-07-30 | |||
| 2024-03-31 | 1.00 segment 10-Q · filed 2024-04-30 | |||
| 2023-09-30 | 1.00 segment 10-Q · filed 2023-10-31 | |||
| 2023-06-30 | 1.00 segment 10-Q · filed 2023-08-02 | |||
| 2023-03-31 | 1.00 segment 10-Q · filed 2023-05-02 | |||
| 2022-09-30 | 1.00 segment 10-Q · filed 2022-11-01 | |||
| 2022-06-30 | 1.00 segment 10-Q · filed 2022-08-02 | |||
| 2022-03-31 | 1.00 segment 10-Q · filed 2022-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |